首页 > 最新文献

Praxis最新文献

英文 中文
[Preoperative Testing in Ophthalmic surgery - Adherence to Guidelines in Northwestern and Central Switzerland]. [眼科手术的术前测试-瑞士西北部和中部的指南依从性]。
Q4 Medicine Pub Date : 2025-10-01 DOI: 10.23785/PRAXIS.2025.10.001
Selina Widmer, Samuel Stähelin, Andreas Zeller, Roland Fischer

Introduction: In Switzerland, patients are referred to their GP for preoperative examinations before cataract surgery. However, according to the ESC Guideline 2022, this is unnecessary. The aim of this study was to assess guideline adherence for preoperative assessment prior to cataract surgery in Northwestern and Central Switzerland. All licensed ophthalmic surgeons were identified via public registers. They were contacted and asked for the preoperative GP form. These forms were then compared to recommendations. Only two of five categories showed a majority of adherence to the guideline. There was no significant difference between regions. Preoperative examinations lead to avoidable workload, additional costs and unnecessary patient examinations.

简介:在瑞士,患者在白内障手术前会被推荐给他们的全科医生进行术前检查。然而,根据ESC指南2022,这是不必要的。本研究的目的是评估瑞士西北部和中部地区白内障手术前术前评估的指南依从性。所有持牌眼科医生均通过公众登记册登记。我们联系了他们并要求他们填写术前全科医生表格。然后将这些表格与推荐表格进行比较。五个类别中只有两个类别显示大多数人遵守指南。区域间无显著差异。术前检查导致本可避免的工作量、额外费用和不必要的患者检查。
{"title":"[Preoperative Testing in Ophthalmic surgery - Adherence to Guidelines in Northwestern and Central Switzerland].","authors":"Selina Widmer, Samuel Stähelin, Andreas Zeller, Roland Fischer","doi":"10.23785/PRAXIS.2025.10.001","DOIUrl":"https://doi.org/10.23785/PRAXIS.2025.10.001","url":null,"abstract":"<p><strong>Introduction: </strong>In Switzerland, patients are referred to their GP for preoperative examinations before cataract surgery. However, according to the ESC Guideline 2022, this is unnecessary. The aim of this study was to assess guideline adherence for preoperative assessment prior to cataract surgery in Northwestern and Central Switzerland. All licensed ophthalmic surgeons were identified via public registers. They were contacted and asked for the preoperative GP form. These forms were then compared to recommendations. Only two of five categories showed a majority of adherence to the guideline. There was no significant difference between regions. Preoperative examinations lead to avoidable workload, additional costs and unnecessary patient examinations.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 10","pages":"344-348"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145725691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The difficulty of pain-assessment in palliative care ESAS and MIDOS - measuring instruments with limited informative value]. 【姑息治疗中疼痛评估的困难——ESAS和MIDOS测量仪器信息价值有限】。
Q4 Medicine Pub Date : 2025-10-01 DOI: 10.23785/PRAXIS.2025.10.003
Hannah Vera Schmieg, Emmanuel Baierlé, Beat Müller

Introduction: Palliative care provides care for seriously ill and dying people, often suffering from pain. Adequate pain treatment is therefore a main focus of the treatment team. Attempts are made to objectify the occurrence of pain using scoring systems such as ESAS or MIDOS. However, the difficulty of objectifying subjective conditions, such as the phenomenon of pain, is problematic and renders the scoring systems poor in content. Only through the complementary efforts of the treatment team, which can be found in the basic attitude of an open-minded recognition of states of suffering, can the best possible approximation to what can be understood as an intersubjective objectification of the pain event be achieved and ultimately the symptom burden be better reduced. However, without negating the difficulties that arise with the objectification of pain.

导读:姑息治疗为重病和垂死的人提供护理,这些人通常遭受痛苦。因此,适当的疼痛治疗是治疗团队的主要关注点。尝试使用评分系统如ESAS或MIDOS客观化疼痛的发生。然而,客观化主观条件(如疼痛现象)的困难是有问题的,这使得评分系统的内容很差。只有通过治疗团队的补充努力,这可以在对痛苦状态的开放认识的基本态度中找到,才能达到最好的近似,可以理解为疼痛事件的主体间客观化,最终更好地减轻症状负担。然而,在不否定痛苦客观化所带来的困难的情况下。
{"title":"[The difficulty of pain-assessment in palliative care ESAS and MIDOS - measuring instruments with limited informative value].","authors":"Hannah Vera Schmieg, Emmanuel Baierlé, Beat Müller","doi":"10.23785/PRAXIS.2025.10.003","DOIUrl":"10.23785/PRAXIS.2025.10.003","url":null,"abstract":"<p><strong>Introduction: </strong>Palliative care provides care for seriously ill and dying people, often suffering from pain. Adequate pain treatment is therefore a main focus of the treatment team. Attempts are made to objectify the occurrence of pain using scoring systems such as ESAS or MIDOS. However, the difficulty of objectifying subjective conditions, such as the phenomenon of pain, is problematic and renders the scoring systems poor in content. Only through the complementary efforts of the treatment team, which can be found in the basic attitude of an open-minded recognition of states of suffering, can the best possible approximation to what can be understood as an intersubjective objectification of the pain event be achieved and ultimately the symptom burden be better reduced. However, without negating the difficulties that arise with the objectification of pain.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 10","pages":"356-359"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145725681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Generalised exanthema with abdominal sepsis]. 全身性皮疹伴腹部败血症。
Q4 Medicine Pub Date : 2025-10-01 DOI: 10.23785/PRAXIS.2025.10.004
Julia Inglin, Aurora Muff, Dominique Oberlin, Reto Nüesch

Introduction: We present the case of a 53-year-old patient who developed DRESS syndrome with hepatopathy and sepsis-like symptoms, including the need for vasoactive agents, while receiving antibiotic therapy. In this report, we show the diagnostic process from the initially suspected and frequent abdominal sepsis to the rare DRESS syndrome. Only after discontinuation of the antibiotic therapy and initiation of steroids did the condition gradually improve.

我们报告了一例53岁的患者,在接受抗生素治疗的同时,出现了DRESS综合征,并伴有肝病和败血症样症状,包括需要血管活性药物。在本报告中,我们展示了从最初怀疑和频繁的腹部败血症到罕见的DRESS综合征的诊断过程。只有在停止抗生素治疗并开始使用类固醇后,病情才逐渐好转。
{"title":"[Generalised exanthema with abdominal sepsis].","authors":"Julia Inglin, Aurora Muff, Dominique Oberlin, Reto Nüesch","doi":"10.23785/PRAXIS.2025.10.004","DOIUrl":"10.23785/PRAXIS.2025.10.004","url":null,"abstract":"<p><strong>Introduction: </strong>We present the case of a 53-year-old patient who developed DRESS syndrome with hepatopathy and sepsis-like symptoms, including the need for vasoactive agents, while receiving antibiotic therapy. In this report, we show the diagnostic process from the initially suspected and frequent abdominal sepsis to the rare DRESS syndrome. Only after discontinuation of the antibiotic therapy and initiation of steroids did the condition gradually improve.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 10","pages":"360-363"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145725601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[How Do Older People Perceive Deprescribing? A systematic integrative literature review]. 老年人如何看待处方?系统综合文献综述]。
Q4 Medicine Pub Date : 2025-10-01 DOI: 10.23785/PRAXIS.2025.10.002
Nadia Exquis, Gabriel Gold, Enos Bernasconi, Tanja Fusi-Schmidhauser

Introduction: Ageing of the general population is a major forthcoming challenge for all healthcare systems. Co-morbidities in geriatrics lead to the prescription of complex polymedications. Deprescribing is a decision-making process that limits the number of inappropriate drugs. Nevertheless, the patient's perspective remains insufficiently studied. An extensive literature search of several databases identified nine studies up to May 2024 that met the criteria for inclusion. Four main themes have been identified around patients' perception of deprescription: 1) the relationship with the general practitioner, 2) the clinical aspects, 3) the psychosocial dimension and 4) the practical aspects. Several factors facilitating deprescribing from the patient's perspective have been identified and can be exploited clinically.

简介:人口老龄化是所有卫生保健系统面临的一个重大挑战。老年病学的合并症导致处方复杂的多种药物。开处方是一个决策过程,它限制了不适当药物的数量。然而,患者的观点仍然没有得到充分的研究。对几个数据库进行了广泛的文献检索,确定了截至2024年5月符合纳入标准的9项研究。围绕患者对去处方的看法,已经确定了四个主要主题:1)与全科医生的关系,2)临床方面,3)社会心理方面和4)实践方面。从患者的角度来看,几个促进处方的因素已经确定,并可以在临床上加以利用。
{"title":"[How Do Older People Perceive Deprescribing? A systematic integrative literature review].","authors":"Nadia Exquis, Gabriel Gold, Enos Bernasconi, Tanja Fusi-Schmidhauser","doi":"10.23785/PRAXIS.2025.10.002","DOIUrl":"https://doi.org/10.23785/PRAXIS.2025.10.002","url":null,"abstract":"<p><strong>Introduction: </strong>Ageing of the general population is a major forthcoming challenge for all healthcare systems. Co-morbidities in geriatrics lead to the prescription of complex polymedications. Deprescribing is a decision-making process that limits the number of inappropriate drugs. Nevertheless, the patient's perspective remains insufficiently studied. An extensive literature search of several databases identified nine studies up to May 2024 that met the criteria for inclusion. Four main themes have been identified around patients' perception of deprescription: 1) the relationship with the general practitioner, 2) the clinical aspects, 3) the psychosocial dimension and 4) the practical aspects. Several factors facilitating deprescribing from the patient's perspective have been identified and can be exploited clinically.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 10","pages":"349-355"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145725652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Fluoroquinolone-associated disability after taking ciprofloxacin]. [服用环丙沙星后氟喹诺酮类药物相关残疾]。
Q4 Medicine Pub Date : 2025-09-01 DOI: 10.23785/PRAXIS.2025.08_09.005
Raffaele Piazza, Katja Weiss, Thomas Rosemann, Beat Knechtle

Introduction: Ciprofloxacin is among the most commonly prescribed Fluoroquinolones. Side effects of Fluoroquinolones include tendinopathies, ar-rhythmias, gastrointestinal discomfort, and neurological symptoms. The definition of a "Fluoroquinolone-associated disability" includes dis-ability, symptoms in several body systems and duration of symptoms after discontinuation of the antibiotic. The pathophysiology of this disease is probably due to a damage to the redox system. We report on a 41-year-old patient who felt pain in his Achilles tendons three days after starting to take ciprofloxacin (of a total of 3 g) and presented as an emergency. In the course of the disease, the pain became chronically disabling and the patient developed paresthesia of both extremities and intermittent heart palpitations. The only tolerated pain medication was Pregabalin. Several MRI examinations showed minimal peritendinitis and irritation of the Achilles tendons. Blood samples indicated probable intracellular damage at low intracellular ATP and coenzyme Q10 values.

简介:环丙沙星是最常用的氟喹诺酮类药物之一。氟喹诺酮类药物的副作用包括肌腱病变、心律失常、胃肠道不适和神经系统症状。“氟喹诺酮类药物相关残疾”的定义包括残疾、多个身体系统的症状和停用抗生素后症状的持续时间。这种疾病的病理生理可能是由于氧化还原系统的损伤。我们报告了一位41岁的患者,他在开始服用环丙沙星(共3g)三天后感到跟腱疼痛,并作为紧急情况提出。在病程中,疼痛成为慢性致残,患者出现四肢感觉异常和间歇性心悸。唯一能忍受的止痛药是普瑞巴林。几个MRI检查显示轻微的腱鞘炎和跟腱刺激。血液样本显示,当细胞内ATP和辅酶Q10值较低时,可能存在细胞内损伤。
{"title":"[Fluoroquinolone-associated disability after taking ciprofloxacin].","authors":"Raffaele Piazza, Katja Weiss, Thomas Rosemann, Beat Knechtle","doi":"10.23785/PRAXIS.2025.08_09.005","DOIUrl":"https://doi.org/10.23785/PRAXIS.2025.08_09.005","url":null,"abstract":"<p><strong>Introduction: </strong>Ciprofloxacin is among the most commonly prescribed Fluoroquinolones. Side effects of Fluoroquinolones include tendinopathies, ar-rhythmias, gastrointestinal discomfort, and neurological symptoms. The definition of a \"Fluoroquinolone-associated disability\" includes dis-ability, symptoms in several body systems and duration of symptoms after discontinuation of the antibiotic. The pathophysiology of this disease is probably due to a damage to the redox system. We report on a 41-year-old patient who felt pain in his Achilles tendons three days after starting to take ciprofloxacin (of a total of 3 g) and presented as an emergency. In the course of the disease, the pain became chronically disabling and the patient developed paresthesia of both extremities and intermittent heart palpitations. The only tolerated pain medication was Pregabalin. Several MRI examinations showed minimal peritendinitis and irritation of the Achilles tendons. Blood samples indicated probable intracellular damage at low intracellular ATP and coenzyme Q10 values.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 8-9","pages":"326-330"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment recommendations for chronic insomnia - cognitive behavioural therapy as first-line treatment]. [慢性失眠的治疗建议-认知行为疗法作为一线治疗方法]。
Q4 Medicine Pub Date : 2025-09-01 DOI: 10.23785/PRAXIS.2025.08_09.003
Helen Slawik, Jens G Acker, Christine Blume, Anna Castelnovo, Katerina Espa Cervena, Miriam Gerstenberg, Elisabeth Hertenstein, Christian Imboden, Thorsten Mikoteit, Christian Mikutta, Lampros Perogamvros, Tifenn Raffray, Carolin Reichert, Verena Reiss, Carlotta L Schneider, Steffi Weidt, Cristina Zunzunegui, Martin Hatzinger, Christoph Nissen, Dagmar A Schmid

Introduction: In addition to the treatment recommendations published by the Special Interest Group (SIG) "Mental Health" (formerly "Sleep Psychiatry") of the Swiss Society for Sleep Research, Sleep Medicine and Chronobiology (SGSSC), the following article focusses on cognitive behavioural therapy for insomnia (CBT-I), its evidence, implementation and application, including in shift work, patients on medication, older people, various formats and non-pharmacological alternatives. Chronic insomnia is a disorder characterised by hyperarousal rather than sleep deprivation. The most effective treatment is bedtime restriction. This can be accompanied by increased daytime sleepiness and concentration deficits, which can be challenging. Furthermore, it is a challenge to find activities for the time that becomes available. The number of therapy places is still insufficient. However, it has been shown that CBT-I is also effective in shortened formats, digitally or when carried out by other professional groups.

简介:除了瑞士睡眠研究、睡眠医学和时间生物学学会(SGSSC)的特殊兴趣小组(SIG)“心理健康”(以前称为“睡眠精神病学”)发表的治疗建议外,以下文章重点关注失眠的认知行为疗法(CBT-I),其证据,实施和应用,包括轮班工作,药物治疗患者,老年人,各种形式和非药物替代方案。慢性失眠是一种以过度觉醒为特征的疾病,而不是睡眠剥夺。最有效的治疗方法是限制就寝时间。这可能伴随着白天嗜睡和注意力不集中,这可能是具有挑战性的。此外,找到合适时间的活动是一个挑战。治疗场所的数量仍然不足。然而,研究表明,CBT-I在缩短格式、数字化或由其他专业团体进行时也很有效。
{"title":"[Treatment recommendations for chronic insomnia - cognitive behavioural therapy as first-line treatment].","authors":"Helen Slawik, Jens G Acker, Christine Blume, Anna Castelnovo, Katerina Espa Cervena, Miriam Gerstenberg, Elisabeth Hertenstein, Christian Imboden, Thorsten Mikoteit, Christian Mikutta, Lampros Perogamvros, Tifenn Raffray, Carolin Reichert, Verena Reiss, Carlotta L Schneider, Steffi Weidt, Cristina Zunzunegui, Martin Hatzinger, Christoph Nissen, Dagmar A Schmid","doi":"10.23785/PRAXIS.2025.08_09.003","DOIUrl":"10.23785/PRAXIS.2025.08_09.003","url":null,"abstract":"<p><strong>Introduction: </strong>In addition to the treatment recommendations published by the Special Interest Group (SIG) \"Mental Health\" (formerly \"Sleep Psychiatry\") of the Swiss Society for Sleep Research, Sleep Medicine and Chronobiology (SGSSC), the following article focusses on cognitive behavioural therapy for insomnia (CBT-I), its evidence, implementation and application, including in shift work, patients on medication, older people, various formats and non-pharmacological alternatives. Chronic insomnia is a disorder characterised by hyperarousal rather than sleep deprivation. The most effective treatment is bedtime restriction. This can be accompanied by increased daytime sleepiness and concentration deficits, which can be challenging. Furthermore, it is a challenge to find activities for the time that becomes available. The number of therapy places is still insufficient. However, it has been shown that CBT-I is also effective in shortened formats, digitally or when carried out by other professional groups.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 8-9","pages":"313-320"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Severe phototoxic side effects of pirfenidone]. [吡非尼酮严重的光毒性副作用]。
Q4 Medicine Pub Date : 2025-09-01 DOI: 10.23785/PRAXIS.2025.08_09.006
Ava Bode, Myriam Wyss Fopp, Jean-Luc Kurzen

Introduction: This case report describes a phototoxic drug reaction in an 81-year-old patient taking the antifibrotic drug pirfenidone for the treatment of idiopathic pulmonary fibrosis. After two hours of sun exposure with sunscreen (SPF 50), the patient developed pruritic, erythematous and scaly lesions on the sun-exposed areas (face, neck, hands and forearms). Physical examination revealed an erythematous exanthema with coarse lamellar scale. A phototoxic reaction to pirfenidone was suspected based on the clinical presentation and distribution pattern. Treatment with topical corticosteroids and discontinuation of pirfenidone led to a marked improvement in symptoms. This case highlights the potential phototoxic risks of pirfenidone, which should be considered especially in dermatological practice where the drug is less known. In addition, important differential diagnoses are outlined and discussed.

简介:本病例报告描述了一位81岁患者服用抗纤维化药物吡非尼酮治疗特发性肺纤维化的光毒性药物反应。在使用防晒系数为50的防晒霜照射两小时后,患者暴露在阳光下的部位(面部、颈部、手部和前臂)出现瘙痒、红斑和鳞状病变。体格检查发现一红斑性疹,有粗糙的板层状鳞片。根据临床表现和分布模式,怀疑是吡非尼酮的光毒性反应。局部皮质类固醇治疗和停用吡非尼酮可显著改善症状。该病例强调了吡非尼酮潜在的光毒性风险,特别是在对该药物知之甚少的皮肤科实践中,应考虑到这一点。此外,还概述和讨论了重要的鉴别诊断。
{"title":"[Severe phototoxic side effects of pirfenidone].","authors":"Ava Bode, Myriam Wyss Fopp, Jean-Luc Kurzen","doi":"10.23785/PRAXIS.2025.08_09.006","DOIUrl":"10.23785/PRAXIS.2025.08_09.006","url":null,"abstract":"<p><strong>Introduction: </strong>This case report describes a phototoxic drug reaction in an 81-year-old patient taking the antifibrotic drug pirfenidone for the treatment of idiopathic pulmonary fibrosis. After two hours of sun exposure with sunscreen (SPF 50), the patient developed pruritic, erythematous and scaly lesions on the sun-exposed areas (face, neck, hands and forearms). Physical examination revealed an erythematous exanthema with coarse lamellar scale. A phototoxic reaction to pirfenidone was suspected based on the clinical presentation and distribution pattern. Treatment with topical corticosteroids and discontinuation of pirfenidone led to a marked improvement in symptoms. This case highlights the potential phototoxic risks of pirfenidone, which should be considered especially in dermatological practice where the drug is less known. In addition, important differential diagnoses are outlined and discussed.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 8-9","pages":"331-333"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Work-related asthma]. 与工作相关的哮喘。
Q4 Medicine Pub Date : 2025-09-01 DOI: 10.23785/PRAXIS.2025.08_09.004
Celine Schumacher, Felix Mangold, Holger Dressel

Introduction: Bronchial asthma is a well-known and common disease. However, there is less knowledge about the fact that asthma can also have an association with the profession. However, this is very relevant because young patients who are in the middle of their working lives are often affected and suffer far-reaching consequences if a diagnosis of occupational asthma is made. The consequences are of a health as well as of a socio-economic nature. Since the asthma symptoms are present inconsistently and corresponding questions about the job may not be asked in the anamnesis, the workplace association is sometimes misunderstood and the diagnosis is therefore delayed. In this article we would like to raise medical awareness of work-related asthma, focus on occupational asthma and the steps to clarify it and finally explain the further procedure regarding suitability for work.

支气管哮喘是一种众所周知的常见病。然而,人们对哮喘也可能与职业有关的事实知之甚少。然而,这是非常相关的,因为处于职业生涯中期的年轻患者如果被诊断为职业性哮喘,往往会受到影响,并遭受深远的后果。其后果既具有健康性质,也具有社会经济性质。由于哮喘症状的出现不一致,并且在记忆中可能没有询问有关工作的相应问题,因此工作场所的联系有时会被误解,因此诊断延迟。在本文中,我们希望提高与工作有关的哮喘的医学认识,重点是职业性哮喘和澄清的步骤,并最终解释有关工作适用性的进一步程序。
{"title":"[Work-related asthma].","authors":"Celine Schumacher, Felix Mangold, Holger Dressel","doi":"10.23785/PRAXIS.2025.08_09.004","DOIUrl":"https://doi.org/10.23785/PRAXIS.2025.08_09.004","url":null,"abstract":"<p><strong>Introduction: </strong>Bronchial asthma is a well-known and common disease. However, there is less knowledge about the fact that asthma can also have an association with the profession. However, this is very relevant because young patients who are in the middle of their working lives are often affected and suffer far-reaching consequences if a diagnosis of occupational asthma is made. The consequences are of a health as well as of a socio-economic nature. Since the asthma symptoms are present inconsistently and corresponding questions about the job may not be asked in the anamnesis, the workplace association is sometimes misunderstood and the diagnosis is therefore delayed. In this article we would like to raise medical awareness of work-related asthma, focus on occupational asthma and the steps to clarify it and finally explain the further procedure regarding suitability for work.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 8-9","pages":"321-325"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ist eine reduzierte DOAK-Dosis bei VTE-Patienten mit hohem ­Rezidivrisiko der vollen Dosis nicht unterlegen? 在复发风险高的VTE患者中,减少DOAK剂量不会低于全剂量吗?
Q4 Medicine Pub Date : 2025-09-01 DOI: 10.23785/PRAXIS.2025.08_09.001
Rahel Eberle, Thomas Rosemann

Introduction:

作品简介:
{"title":"Ist eine reduzierte DOAK-Dosis bei VTE-Patienten mit hohem ­Rezidivrisiko der vollen Dosis nicht unterlegen?","authors":"Rahel Eberle, Thomas Rosemann","doi":"10.23785/PRAXIS.2025.08_09.001","DOIUrl":"https://doi.org/10.23785/PRAXIS.2025.08_09.001","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 8-9","pages":"307"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A case of acute fascioliasis in a traveler returning from Australia and Vanuatu]. [1例从澳大利亚和瓦努阿图返回的旅行者感染急性片形吸虫病]。
Q4 Medicine Pub Date : 2025-09-01 DOI: 10.23785/PRAXIS.2025.08_09.008
Michelle Küting, Irene Abela, Felix Grimm, Marisa Kälin

Introduction: A patient presented with fever and upper abdominal pain after returning from Australia and Vanuatu. Pronounced eosinophilia served as a diagnostic clue, leading to a successful treatment of acute fascioliasis with Triclabendazole. Following the therapy, the patient experienced complete symptom relief.

患者从澳大利亚和瓦努阿图返回后出现发烧和上腹部疼痛。明显的嗜酸性粒细胞增多作为诊断线索,导致成功的治疗急性片形吸虫病与三氯苯达唑。治疗后,患者症状完全缓解。
{"title":"[A case of acute fascioliasis in a traveler returning from Australia and Vanuatu].","authors":"Michelle Küting, Irene Abela, Felix Grimm, Marisa Kälin","doi":"10.23785/PRAXIS.2025.08_09.008","DOIUrl":"10.23785/PRAXIS.2025.08_09.008","url":null,"abstract":"<p><strong>Introduction: </strong>A patient presented with fever and upper abdominal pain after returning from Australia and Vanuatu. Pronounced eosinophilia served as a diagnostic clue, leading to a successful treatment of acute fascioliasis with Triclabendazole. Following the therapy, the patient experienced complete symptom relief.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 8-9","pages":"337-341"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Praxis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1